MTIs inhibit STAT3 phosphorylation and in MTI-treated MDA breast cancer cells, where c-Src promotes STAT3 activation, we detected the inhibition of c-Src- and IL-6-mediated STAT3 phosphorylation and activation, effects that were greatly enhanced by RKIP over expression. This evidence concerns the gene IL6 and breast carcinoma.